Xampla creates plant protein material for commercial use.
Xampla has raised €29M across 4 funding rounds from 11 investors, most recently a Series A round in Sep 2025. Based in Cambridge, UK; founded 2018; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-09-04 | Series A | €14M | Amadeus Capital Partners,BGF,existing backers,Horizons Ventures,Matterwave Ventures | View deal → |
| 2024-01-30 | Other | €6.4M | Amadeus Capital Partners,Cambridge Angels,Cambridge Enterprise,CIECH Ventures,Horizon Ventures,Martlet Capital | View deal → |
| 2021-01-08 | Seed | €6.8M | — | View deal → |
| 2020-04-29 | Seed | €2.3M | Amadeus Capital Partners,University of Cambridge Enterprise | View deal → |
